Edition:
India

People: Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

1.60USD
1:30am IST
Change (% chg)

$-0.22 (-12.09%)
Prev Close
$1.82
Open
$1.60
Day's High
$1.69
Day's Low
$1.50
Volume
158,897
Avg. Vol
63,092
52-wk High
$5.10
52-wk Low
$1.50

Denby, William 

Mr. William C. Denby III is an Independent Director of the Company. From 2002-2014, Mr. Denby became a director of the Company in August 2014. From 2002-2014, Mr. Denby was Senior Vice President, Commercial Operations at Santarus, Inc. which was acquired by Salix Pharmaceuticals. Inc. in January of 2014. At Santarus, he directed all commercial functions including Sales, Marketing, Market Research, Customer Service, Managed Care, New Product Planning and other various functions. Prior to Santarus, he was Senior Vice President, Commercial Operations and Senior Vice President, Sales and Marketing at Agouron Pharmaceuticals, Inc. Earlier in his career, he spent approximately 20 years in various leadership management roles at Marion Merrell Dow, Inc. Mr. Denby has a Bachelor of Arts degree in English and Business from State University of New York at Fredonia and a Masters of Business Administration from Rockhurst College. ss

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Williams

540,000

Dennis Carlo

2,562,760

Robert Hopkins

1,307,310

David Marguglio

1,456,640

Karen Daniels

259,891

Thomas Moll

--
As Of  31 Dec 2017